Breast Cancer
2023 Breast Cancer Research Highlights
- Inhibition of Myeloid-Derived Suppressor Cell Biogenesis to Improve the Efficacy of Immune Checkpoint Inhibitors in Triple-Negative Breast Cancer
- Epigenetic Factor CECR2 as a Potential Target in Breast Cancer Metastasis
- The CDMRP Remembers Dr. Susan Love
- Dual-Loading Antibody-Drug Conjugates for Combating Breast Cancer Tumor Heterogeneity and Drug Resistance
- Functional Mechanism and Targeting of Metadherin in Breast Cancer
- Targeting GM-CSF to Inhibit Development of Leptomeningeal Disease from Breast Cancer
- A Novel Tubulin Inhibitor to Overcome Taxane Resistance in Metastatic Breast Cancer
Last updated Thursday, October 26, 2023